期刊文献+
共找到314篇文章
< 1 2 16 >
每页显示 20 50 100
Transfection of the Human Sodium/Iodide Symporter(NIS) Gene with Liposomes and the Expression of the NIS Protein in Human Lung A549 Cancer Cells 被引量:1
1
作者 严煜 张宏飞 +1 位作者 张裕东 王晓谭 《Chinese Journal of Clinical Oncology》 CSCD 2008年第1期30-34,共5页
OBJECTIVE To examine the possibility of human sodium iodide symporter (hNIS) protein expression in lung cancer cells. METHODS Human lung A549 cancer cells were thawed and cultured in vitro. The cells were divided in... OBJECTIVE To examine the possibility of human sodium iodide symporter (hNIS) protein expression in lung cancer cells. METHODS Human lung A549 cancer cells were thawed and cultured in vitro. The cells were divided into an experimental group transfected with a recombinant pcDNA3-hNIS plasmid and a control group transfected only with a pcDNA3 plasmid. The recombinant plasmid vector encoding the hNIS gene (pcDNA3-hNIS) was amplified, purified and identified. The hNIS gene was followed by DNA sequencing. A Western blot and an immunohistochemical assay were applied to detect the hNIS protein expression in the transfected human lung A549 cancer cells. RESULTS Restriction enzyme digestion and DNA sequencing results showed the size and direction of the inserted gene in the recombinant pcD- NA3-hNIS plasmid was correct. The Western blot method and immunohistochemical analysis showed a positive NIS protein expression in the experimental group. The NIS protein was detected mainly in the cell membranes showing a positive rate up to 70.6% with no expression of the NIS protein in the control group. There was a significant difference between two groups (P=0.000). CONCLUSION The hNIS gene was transfected effectively into human lung A549 cancer cells mediated by Lipofectamine 2000, and was expressed with its protein in vitro. 展开更多
关键词 human sodium/iodide symporter (SIN) non-small-cell-lung cancer (NSCLC) gene transfection LIPOSOME radioiodide therapy
下载PDF
Radiofrequency induction on sodium/iodide symporter expression of thyroid cancer
2
作者 Youxin Tian Qinjiang Liu Yaqiong Ni 《The Chinese-German Journal of Clinical Oncology》 CAS 2013年第11期516-520,共5页
Objective; The aim of this study was to investigate the effects of radiofrequency treatment on sodium/iodide symporter expression of thyroid cancer ceils. Methods: In 29 thyroid cancer patients with low or no express... Objective; The aim of this study was to investigate the effects of radiofrequency treatment on sodium/iodide symporter expression of thyroid cancer ceils. Methods: In 29 thyroid cancer patients with low or no expression of soda / iodide symporter, the radio frequency combined 1311 therapy was used, the whole-body scintigraphy and serum Ig were detected before and after the radiofrequency treatment. Results: The whole-body scintigraphy showed that 4 cases (4/29) before radiofrequenc_y treatment had positive iodine uptake, 19 cases (19/29) two weeks after radiofrequency treatment had the positive iodine uptake, 12 cases (12/29) four weeks after radiofrequency treatment had the positive iodine uptake. Four weeks after radiofrequency treatment, 5 cases had increased serum Ig levels, 17 cases had decreased serum Ig levels, 7 cases showed no change. 25 cases (25/29) were effective, 15 cases (15/29) were cured. Conclusion: The radiofrequency induced the non-expressed the sodium/iodide symporter of thyroid cancer cells regain the iodine intake ability, it improved the clinical efficacy of 131I therapy in dedifferentiated thyroid cancer. 展开更多
关键词 thyroid carcinoma radiofrequency ablation sodium/iodide symporter
下载PDF
Correlation analysis between serum β2-MG and sodium/iodide symporter in patients with thyroid carcinoma
3
作者 Xiaofeng Hou Qinjiang Liu Shihong Ma 《The Chinese-German Journal of Clinical Oncology》 CAS 2013年第2期65-67,共3页
Objective: The aim of our study was to investigate the correlation between the expression of sodium/iodide symporter, serum levels of β2-MG and prognosis of thyroid carcinoma patients. Methods: Ninty-five cases wit... Objective: The aim of our study was to investigate the correlation between the expression of sodium/iodide symporter, serum levels of β2-MG and prognosis of thyroid carcinoma patients. Methods: Ninty-five cases with thyroid carcinoma, using enzyme-linked immunosorbent assay with double-antibody sandwich to detect the serum β2-MG levels and immunehistochemistry to detect NIS expression of thyroid cancer tissue. Results: Thirty-seven cases showed positive expression of sodium/iodide symporter (38.9%) and 30 cases showed positive expression of β2-MG (31.57%). There were significant differences of NIS expression (X2 = 8.207, P = 0.017) and β2-MG expression (X2 = 10.121, P = 0.006) between different pathological types of thyroid carcinoma, but there was no correlation between the positive rate of the two research groups (r = -0.546, P = 0.633). The significant differences was observed in expression of sodium/iodide symporter (X2 = 9.272, P=0.002) and expression of β2-MG (X2 = 4.441, P = 0.035) between the group with neck lymph node metastasis and the group without neck lymph node metastasis and both positive rate was significantly negatively correlated (r = -1.000, P = 0.000). The significant differences was observed in expression of sodium/iodide symporter (X2 = 9.272, P = 0.002) and expression of β2-MG (X2 = 3.867, P = 0.043) between the group with distant organ metastasis and the group without distant organ metastasis (X2 = 11.985, P = 0.001) and both positive rate was significantly negatively correlated (r = -1.000, P = 0.000). Conclusion: There are significantly negatively correlated between neck lymph node metastasis, distant organ metastasis and expression of sodium/iodide symporter and expression of β2-MG. Thyroid cancer lymph node and distant organ metastasis, the tumor tissue NIS expression and serum levels of β2-MG is significantly negatively correlated. The detection of serum β2-MG provides clinical reference value for the effects on radionuclide therapy and prognosis assessment of thyroid carcinoma. Serum β2-MG levels is negatively correlated with prognosis in thyroid cancer patients. 展开更多
关键词 thyroid carcinoma sodium/iodide symporter Β2-MICROGLOBULIN
下载PDF
Human sodium/iodide symporter gene induced iodine uptake in human lung adenocarcinoma via baculovirus
4
作者 GUO Rui ZHANG Yifan LIANG Sheng ZHANG Miao JIANG Xufeng LI Biao 《Nuclear Science and Techniques》 SCIE CAS CSCD 2010年第2期99-105,共7页
To investigate human sodium/iodide symporter (hNIS) induced iodine uptake in human lung adenocarcinoma via baculovirus, a recombinant baculovirus encoding hNIS gene was constructed under the control of CMV promoter (B... To investigate human sodium/iodide symporter (hNIS) induced iodine uptake in human lung adenocarcinoma via baculovirus, a recombinant baculovirus encoding hNIS gene was constructed under the control of CMV promoter (Bac-CMV-hNIS). In vitro, baculovirus infected A549 cells accumulated about 27 times more 125I than that of noninfected cells. The 125I uptake was maximal after 30-min incubation of the cells, and efflux of the radioactivity was rapid, with 50% lost during the first 2 min after 125I-containing medium had been replaced by nonradioactive medium. Competition experiments in the presence of sodium perchlorate revealed a dose-dependent decrease of 125I uptake. Bac-CMV-hNIS infected tumor cells were selectively killed by exposure to 131I, as revealed by clonogenic assays. In nude mice, Bac-CMV-hNIS infected A549 cells accumulated more 131I than that of the control monitored by 1-h scintigraphy after 131I administration. The transduction of hNIS gene through baculovirus is sufficient to induce iodine transporting in A549 cells in vitro and in vivo, outlining the potential of this novel tumor gene imaging approach. But a rapid efflux of radioactivity from the tumor was shown in vivo and the in vivo therapy test showed no sign of effect. 展开更多
关键词 重组杆状病毒 基因编码 吸收剂量 肺腺癌 转运体 诱导 125I标记 巨细胞病毒
下载PDF
The effects of thyroid-stimulating hormone,estradiol and prolactin on sodium/iodide symporter mRNA expression in mouse lactating mammary gland cells under different iodine levels
5
作者 刘丽香 《China Medical Abstracts(Internal Medicine)》 2017年第1期18-19,共2页
Objective The present study investigated the sodium/iodide symporter mRNA expression in mouse lactating mammary gland cells under different iodine levels and the effects of thyroid-stimulating hormone(TSH),estradiol(E... Objective The present study investigated the sodium/iodide symporter mRNA expression in mouse lactating mammary gland cells under different iodine levels and the effects of thyroid-stimulating hormone(TSH),estradiol(E2)and prolactin(PRL)on NIS mRNA expression in mouse lactating mammary gland cells. 展开更多
关键词 mRNA PRL NIS TSH The effects of thyroid-stimulating hormone estradiol and prolactin on sodium/iodide symporter mRNA expression in mouse lactating mammary gland cells under different iodine levels
原文传递
Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter 被引量:7
6
作者 Xiao-Feng Gao Tie Zhou Guang-Hua Chen Chuan-Liang Xu Ye-Lei Ding Ying-Hao Sun 《Asian Journal of Andrology》 SCIE CAS CSCD 2014年第1期120-123,共4页
Radioiodine therapy, the most effective form of systemic radiotherapy available, is currently useful only for thyroid cancer because of the thyroid-specific expression of the human sodium iodide symporter (hNIS). He... Radioiodine therapy, the most effective form of systemic radiotherapy available, is currently useful only for thyroid cancer because of the thyroid-specific expression of the human sodium iodide symporter (hNIS). Here, we explore the efficacy of a novel form of gene therapy using prostate-specific membrane antigen (PSMA) promoter-mediated hNIS gene transfer followed by radioiodine administration for the treatment of castration-resistant prostate cancer (CRPC). The androgen-dependent C33 LNCaP cell line and the androgen-independent C81 LNCaP cell line were transfected by adenovirus. PSMA promoter-hNIS (Ad.PSMApro-hNIS) or adenovirus.cytomegalovirus-hNIS containing the cytomegalovirus promoter (Ad.CMM-hNIS) or a control virus. The iodide uptake was measured in vitro. The in vivo iodide uptake by C81 cell xenografts in nude mice injected with an adenovirus carrying the hNIS gene linked to PSMA and the corresponding tumor volume fluctuation were assessed. Iodide accumulation was shown in different LNCaP cell lines after Ad.PSMApro-hNIS and Ad.CMV-hNIS infection, but not in different LNCaP cell lines after adenovirus.cytomegalovirus (Ad.CMV) infection. At each time point, higher iodide uptake was shown in the C81 cells infected with Ad.PSMApro-hNIS than in the C33 cells (P 〈 0.05). An in vivo animal model showed a significant difference in 1311 radioiodine uptake in the tumors infected with Ad.PSMApro-hNIS, Ad.CMV-hNIS and control virus (P 〈 0.05) and a maximum reduction of tumor volume in mice infected with Ad.PSMApro-hNIS. These results show prostate-specific expression of the hNIS gene delivered by the PSMA promoter and effective radioiodine therapy of CRPC by the PSMA promoter-driven hNIS transfection. 展开更多
关键词 genetic therapy prostate-specific membrane antigen (PSMA) prostatic neoplasms sodium-iodide symporter
下载PDF
Bibracchial Lariat Ethers(Ⅰ)——The Synthesis and Crystal Structure of the N,N'-bis(2-Methoxy-1-Naphthylmethyl)-4,13-Diaza-18-Crown-6 Sodium Iodide Complex
7
作者 Ge Yuhua, Wang Defen and Hu Hongweng (Department of Chemistry, Nanjing University, Nanjing)Zhou Zhongyuan and Yu Kaibei (Chengdu Center of Analysis and Determination, Academic Sinica, Chengdu) 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 1992年第1期48-52,共5页
Diaza Crown ethers are versatile complexing reagents, their complexing abilities are dramatically modified by the electron donating atoms on substituents attached to the nitrogen if they can give a three-dimensional c... Diaza Crown ethers are versatile complexing reagents, their complexing abilities are dramatically modified by the electron donating atoms on substituents attached to the nitrogen if they can give a three-dimensional cavity as in cryptates. Hence the synthesis and characterization of bibracchial lariat ethers (BIBLES) have received much attention. In the preparation of new BIBLES, a complex Ⅱ was unexpectedly obtained. 展开更多
关键词 Bibracchial lariat ether Diaza-18-crown-6 derivative Crystal structure sodium iodide complex
下载PDF
Comparison of Aggressiveness Behavior of Chloride and Iodide Solutions on 304 and 304L Stainless Steel Alloys 被引量:1
8
作者 Shaymaa Mahdi Salih Ibtehal K. Shakir Abdulkareem M. A. Al-Sammarraie 《Materials Sciences and Applications》 2017年第12期889-898,共10页
The aggressive effect of chloride anion in comparison to iodide anion on the pitting corrosion attack of 304 and 304L stainless steel (SS) alloys was investigated by using the cyclic potentiodynamic polarization test ... The aggressive effect of chloride anion in comparison to iodide anion on the pitting corrosion attack of 304 and 304L stainless steel (SS) alloys was investigated by using the cyclic potentiodynamic polarization test at 0.6 M Sodium Halide salts (NaX) solution and different temperatures. The two alloys 304 and 304L SS suffered from severe pitting corrosion at room temperature up to 50&deg;C in a chloride containing solution with the higher resistance observed for 304L in comparison to the 304 while on pits were detected in iodide solution for both alloys. The pitting potentials of the two alloys in 0.6 M NaCl solution reduced with the increase of the temperature. Examination of the alloys’ surfaces was conducted by using the scanning electron microscopes where it revealed that the occurrence of pitting attack seems like hemispherical or irregular pits with different sizes. 展开更多
关键词 STAINLESS Steel PITTING Corrosion sodium HALIDE iodide
下载PDF
Adenovirus-mediated and tumor-specific transgene expression of the sodium-iodide symporter from the human telomerase reverse transcriptase promoter enhances killing of lung cancer cell line in vitro 被引量:7
9
作者 SHI Yi-zhen ZHANG Jun +2 位作者 LIU Zeng-li DU Shou-ying SHEN Yong-mei 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第15期2070-2076,共7页
Background The sodium-iodide symporter (NIS) protein can mediate the active radioiodine uptake.The human telomerase reverse transcriptase (hTERT) promoter is known to be selectively reactivated in majority of tumo... Background The sodium-iodide symporter (NIS) protein can mediate the active radioiodine uptake.The human telomerase reverse transcriptase (hTERT) promoter is known to be selectively reactivated in majority of tumors and hence could be used for tumor targeting.We constructed a recombinant adenovirus containing the human sodium iodide symporter (hNIS) gene directed by the hTERT promoter, characterized the ability of infected cells in uptaking iodide, and explored the therapeutic efficacy of 131I in a lung cancer cell line in vitro.Methods The hTERT promoter was amplified by PCR from DNA isolated from log-phase HepG2 cells, subcloned into lineralized FL*-hNIS/pcDNA3, and then the hTERT-hNIS sequence was subcloned into the shuttle plasmid pAdTrack.The recombinant adenovirus Ad-hTERT-hNIS was constructed by AdEasy system.A positive control adenovirusAd-CMV-hNIS and a negative control adenovirus Ad-CMV were created similarly.A549 cells were transduced with recombinant adenoviruses.125I uptake studies and sodium perchlorate suppression studies were used to confirm hNIS expression and function.Toxic effects of 131I on tumor cells were studied by in vitro clonogenic assay.Results We first successfully constructed an adenovirus mediated transgene expression system of the hNIS under the control of hTERT promoter.When infected with recombinant adenovirus constructs expressing hNIS directed by hTERTand CMV-promoters (Ad-hTERT-hNIS and Ad-CMV-hNIS, respectively), the lung cancer cell line A549 had increased ability to uptake radioiodide up to 23- and 30- fold compared to the control parental cells, respectively.The radioiodide uptake ability of both the Ad-CMV-hNIS and Ad-hTERT-hNIS transduced cell lines were repressed 11-fold by sodium perchlorate (NaCIO4).The subsequent in vitro clonogenic assay of the infected A549 cell line was further repressed to 23% (Ad-CMV-hNIS) and 30% (Ad-hTERT-hNIS) of the control group after receiving radioiodide for 7 hours (P 〈0.001).Conclusion Our preliminary study indicates that an adenovirus mediated transgene expression system of the hNIS under the control of hTERT promoter has the potential to become an effective wide-spectrum yet highly specific anti-cancer strategy. 展开更多
关键词 sodium-iodide symporter INFECTION ADENOVIRIDAE iodine radioisotopes colony-forming units assay
原文传递
甲状腺癌碘-131治疗抵抗发生的分子机制研究进展
10
作者 刘诗琪 王辉 冯方 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2024年第7期915-921,共7页
甲状腺癌是内分泌系统最常见的恶性肿瘤,其中分化型甲状腺癌(differentiated thyroid carcinoma,DTC)占90%以上。多数DTC患者经过系统治疗后预后良好,但少数患者肿瘤原发灶或转移灶出现失分化现象,进展为放射性碘难治性DTC(radioiodine-... 甲状腺癌是内分泌系统最常见的恶性肿瘤,其中分化型甲状腺癌(differentiated thyroid carcinoma,DTC)占90%以上。多数DTC患者经过系统治疗后预后良好,但少数患者肿瘤原发灶或转移灶出现失分化现象,进展为放射性碘难治性DTC(radioiodine-refractory DTC,RAIR-DTC),预后明显变差,是甲状腺癌致死的主要原因。钠碘转运体(sodium iodide symporter,NIS)的表达和功能异常,是导致甲状腺癌碘-131治疗抵抗的主要原因,其发生受遗传学改变、表观遗传学改变、肿瘤微环境作用、自噬作用等多因素影响。遗传学改变如BRAF基因的V600E位点突变、RET/PTC基因重排等导致致癌信号通路的激活,直接或间接地影响NIS的表达及其在细胞膜上的正常定位。表观遗传学调控特定基因的表达模式,调节NIS的表达水平,进而影响甲状腺细胞的碘摄取功能。肿瘤微环境中的免疫细胞、细胞因子和细胞外基质等成分也可能通过降低NIS的表达水平和/或干扰其在细胞膜上的正常功能导致细胞碘摄取障碍。此外,自噬作为一种细胞内部的代谢调节机制,也可以调节NIS的表达及其在细胞内的分布,从而影响碘的摄取和碘-131治疗的敏感性。通过综述以上因素在甲状腺癌失分化中的作用机制,可以更全面地理解RAIR-DTC的发生和发展过程,有助于探寻新的治疗靶点,改善预后,并为患者提供更有效的个体化治疗策略。 展开更多
关键词 分化型甲状腺癌 失分化 放射性碘 钠碘转运体
下载PDF
钠碘同向转运体表达与功能调控的研究进展
11
作者 喻浩威 丛馨 苏家增 《生理科学进展》 CAS 北大核心 2024年第4期334-339,共6页
钠碘同向转运体(sodium iodine symporter)广泛分布于人体各个器官,是器官转运I-的结构和功能基础。钠碘同向转运体主要表达在细胞的基底侧膜上,为各种生命活动提供所需的I-。目前已知,钠碘同向转运体的调控机制涉及激素、细胞因子、转... 钠碘同向转运体(sodium iodine symporter)广泛分布于人体各个器官,是器官转运I-的结构和功能基础。钠碘同向转运体主要表达在细胞的基底侧膜上,为各种生命活动提供所需的I-。目前已知,钠碘同向转运体的调控机制涉及激素、细胞因子、转录因子及信号分子的作用。此外,钠碘同向转运体作为甲状腺癌的重要治疗靶点逐渐受到关注,然而在治疗过程中唾液腺等其他器官吸收放射性碘而产生的并发症也值得重视。本文重点综述了钠碘同向转运体的表达、作用及其调控机制的研究进展,旨在为临床干预钠碘同向转运体异常相关疾病进程提供新思路。 展开更多
关键词 钠碘同向转运体 甲状腺 乳腺 唾液腺
下载PDF
利用示波器测量μ子寿命
12
作者 郝佳欣 郭戈 孙保华 《大学物理》 2024年第3期55-59,共5页
μ子是地球表面的主要宇宙射线,可以通过碘化钠等常见闪烁体探测器进行探测.本文介绍了一种利用高采样率的示波器对探测器所捕捉到的μ子信号及其衰变信号进行数字化采集、线下软件分析的实验方法,进而得到μ子寿命.本实验操作相对简单... μ子是地球表面的主要宇宙射线,可以通过碘化钠等常见闪烁体探测器进行探测.本文介绍了一种利用高采样率的示波器对探测器所捕捉到的μ子信号及其衰变信号进行数字化采集、线下软件分析的实验方法,进而得到μ子寿命.本实验操作相对简单,可以在不使用放射源和传统核电子学的情况下,拓展为近代物理或专业物理实验中的一个粒子探测前沿项目. 展开更多
关键词 μ子寿命 示波器 碘化钠探测器 符合测量
下载PDF
离子色谱法测定9V、11A、19A型肺炎球菌多糖中碘化钠残留量
13
作者 朱向国 王立勇 +2 位作者 张晓康 马庆华 郑佳 《化学试剂》 CAS 2024年第6期107-111,共5页
建立检测9V、11A、19A型肺炎球菌多糖中碘化钠残留量的离子色谱方法,并进行验证。以Dionex IonPac AS11-HC阴离子交换层析柱为分析柱,Dionex IonPac AG11-HC阴离子交换柱为保护柱;采用低浓度氢氧化钠溶液为淋洗液等度洗脱,以电化学检测... 建立检测9V、11A、19A型肺炎球菌多糖中碘化钠残留量的离子色谱方法,并进行验证。以Dionex IonPac AS11-HC阴离子交换层析柱为分析柱,Dionex IonPac AG11-HC阴离子交换柱为保护柱;采用低浓度氢氧化钠溶液为淋洗液等度洗脱,以电化学检测器进行检测。碘化钠的质量浓度在0.01~1.00μg/mL的范围具有良好的线性关系,决定系数R 2可达到0.9999,检出限为0.002μg/mL,定量限为0.010μg/mL。3个型别肺炎球菌多糖在低、中、高3个加标水平下的平均回收率为94.40%~103.91%,相对标准偏差(RSD)为0.17%~1.71%,均满足检测要求。方法无需复杂的样品前处理过程,测定快速,灵敏度高,结果准确,重复性好,可用于9V、11A、19A型肺炎球菌多糖中痕量碘化钠残留的检测。 展开更多
关键词 肺炎球菌多糖 离子色谱 电化学检测器 碘化钠 残留检测
下载PDF
溴结构域蛋白4经PTEN/PI3K/AKT通路对甲状腺乳头状癌细胞摄碘相关指标影响的研究
14
作者 刘帆 张雅兰 +1 位作者 柴雅晖 宋爱琳 《兰州大学学报(医学版)》 2023年第2期6-12,19,共8页
目的研究溴结构域蛋白4(BRD4)在甲状腺乳头状癌(PCT)中的表达水平及其抑制剂JQ1对PCT细胞增殖、迁移能力的影响,进一步探索影响摄碘能力的调控机制。方法采用实时荧光定量聚合酶链反应(qRT-PCR)技术及蛋白质印迹法分别检测BRD4在正常甲... 目的研究溴结构域蛋白4(BRD4)在甲状腺乳头状癌(PCT)中的表达水平及其抑制剂JQ1对PCT细胞增殖、迁移能力的影响,进一步探索影响摄碘能力的调控机制。方法采用实时荧光定量聚合酶链反应(qRT-PCR)技术及蛋白质印迹法分别检测BRD4在正常甲状腺细胞Nthy-ori 3-1及人PCT细胞TPC-1、K1的表达水平。采用CCK-8及划痕实验分别检测JQ1对TPC-1、K1细胞增殖及迁移能力的影响。采用高内涵细胞成像与分析系统观察TPC-1、K1细胞在JQ1作用下的形态及数目变化。采用qRT-PCR技术检测影响PCT摄碘能力相关基因的表达。结果BRD4在PCT细胞及癌组织中高表达。JQ1对TPC-1、K1细胞增殖能力呈时间及浓度依赖性抑制。TPC-1、K1细胞的48 h半抑制浓度分别为(9.045±0.772)、(14.169±1.406)μmol/L。JQ1可以抑制TPC-1、K1细胞的迁移,且具有统计学意义(P<0.05)。JQ1分别作用于TPC-1、K1细胞48 h后,实验组BRD4、磷脂酰肌醇3激酶(PI3K)和蛋白激酶B(AKT)的mRNA表达水平降低。第10号染色体同源缺失性磷酸酶-张力蛋白基因(PTEN)、钠-碘转运蛋白的mRNA表达升高。结论BRD4在PCT中呈现高表达状态。JQ1可有效抑制BRD4的表达,并影响PTEN/PI3K/AKT通路从而抑制PCT细胞的增殖及迁移,使得其摄碘能力增加。 展开更多
关键词 溴结构域蛋白4 甲状腺乳头状癌 磷脂酰肌醇3激酶 蛋白激酶B 钠-碘转运蛋白
下载PDF
海藻与碘化钾对甲功正常大鼠碘脱逸影响的比较研究 被引量:1
15
作者 禹姗姗 高天舒 《辽宁中医药大学学报》 CAS 2023年第11期64-67,共4页
目的基于前期的临床研究结果,该研究将主要探讨海藻与碘化钾对甲功正常大鼠碘脱逸的影响。方法将Wistar大鼠随机分为正常对照组(NC)48只,碘化钾组(IG)60只,海藻组(SG)60只,海藻甘草组(SLG)10只。NC每日灌服2 mL双蒸水,连续2周;IG每天灌... 目的基于前期的临床研究结果,该研究将主要探讨海藻与碘化钾对甲功正常大鼠碘脱逸的影响。方法将Wistar大鼠随机分为正常对照组(NC)48只,碘化钾组(IG)60只,海藻组(SG)60只,海藻甘草组(SLG)10只。NC每日灌服2 mL双蒸水,连续2周;IG每天灌胃浓度为0.45 mg/mL的碘化钾溶液2 mL,连续两周;SG每天灌胃海藻颗粒溶液2 mL,连续2周。SLG在灌胃2周海藻颗粒溶液后,改为海藻:甘草为5∶1的配伍比例再继续灌胃1周。在未给予处理因素的前24 h(0 d),灌胃后的12 h、1、2、3、7、14、21 d,每组分别取材8只大鼠。ICP-MS法测各组大鼠血碘浓度水平,western-blot法测甲状腺NIS蛋白表达量。结果与IG各时间点相比,SG除第1天血清碘水平高于IG外(P<0.05);其余各时间点血清碘水平均低于IG(P<0.05)。SG各时间点血清碘水平比较,SG2 d与SG 14 d无统计学意义(P>0.05);SG 3 d与SG 14 d、SLG 21 d无统计学意义(P>0.05);其余SG组各时间点血清碘水平均有统计学意义(P<0.01)。SG各时间点血清碘水平比较如下:SG 1 d>SG 7 d>SG 3 d>SG 21 d>SG 14 d>SG2 d>SG 0 d。IG各时间点血清碘水平比较,IG1 d与IG14 d无统计学意义(P>0.05),IG 2 d、IG 3 d、IG 7 d血清碘水平无统计学意义(P>0.05),IG其余各时间点血清碘水平均有统计学意义(P<0.01)。IG各时间点血清碘水平比较如下:IG 2 d>IG 3 d>IG 7 d>IG 14 d>IG 1 d>IG 0 d。与IG各时间点相比,SG药物干预后的各时间点NIS蛋白水平均低于IG(P<0.05)。NC 3 d与IG 3 d无统计学意义(P>0.05);NC 14 d与IG 14 d无统计学意义(P>0.05);药物干预后NIS蛋白表达水平具体如下:12 h:IG>NC>SG;1 d:IG>SG>NC;2 d:NC>IG>SG;3 d:NC>SG>IG;7 d:IG>NC>SG;14 d:IG>NC>SG;SLG 21 d>SG 14 d。结论与碘化钾相比,海藻在甲功正常大鼠机体不易出现碘脱逸;海藻与甘草5∶1配伍应用可提高甲功正常大鼠机体NIS蛋白的表达量。 展开更多
关键词 碘阻断 碘脱逸 钠碘转运体 海藻 WISTAR大鼠
下载PDF
NaI/TBHP催化氧化芳基磺酰肼与取代苯乙炔合成炔基砜
16
作者 陈碧海 王知情 江国防 《中南大学学报(自然科学版)》 EI CAS CSCD 北大核心 2023年第8期3012-3022,共11页
芳基磺酰肼在NaI/TBHP催化氧化体系下形成砜基自由基,与取代苯乙炔反应,制备炔基砜。对反应条件进行筛选,获得最优条件,即以0.7 mmol对甲基苯磺酰肼、0.5 mmol苯乙炔、1.0 mmol碘化钠(NaI)为催化剂,2.0 mmol的叔丁基过氧化氢(TBHP)为氧... 芳基磺酰肼在NaI/TBHP催化氧化体系下形成砜基自由基,与取代苯乙炔反应,制备炔基砜。对反应条件进行筛选,获得最优条件,即以0.7 mmol对甲基苯磺酰肼、0.5 mmol苯乙炔、1.0 mmol碘化钠(NaI)为催化剂,2.0 mmol的叔丁基过氧化氢(TBHP)为氧化剂,4.0 mL无水乙醇为溶剂,在80℃时搅拌反应8 h。研究结果表明:在此条件下,该反应底物适用性好,对芳基磺酰肼和取代苯乙炔有良好的耐受性;该反应经过磺酰基自由基与芳基乙炔进行自由基加成得到烯基自由基,然后夺取碘自由基生成(E)-β-碘代烯基砜,脱掉碘化氢得到炔基砜。 展开更多
关键词 芳基磺酰肼 取代苯乙炔 碘化钠 叔丁基过氧化氢 炔基砜
下载PDF
逆转钠碘转运蛋白在治疗放射性碘难治性分化型甲状腺癌中的研究进展
17
作者 郭宏鹏 李尤 +5 位作者 张金辉 何明芮 俞建华 张艺彤 刘俊良 孙成林 《沈阳医学院学报》 2023年第3期306-311,共6页
分化型甲状腺癌(differentiated thyroid carcinoma,DTC)的常规治疗手段包括手术、放射性碘治疗和促甲状腺激素抑制性治疗,大部分DTC患者在治疗后效果较好,但部分DTC去分化影响钠碘转运蛋白(sodium iodide symporter,NIS)的表达,无法进... 分化型甲状腺癌(differentiated thyroid carcinoma,DTC)的常规治疗手段包括手术、放射性碘治疗和促甲状腺激素抑制性治疗,大部分DTC患者在治疗后效果较好,但部分DTC去分化影响钠碘转运蛋白(sodium iodide symporter,NIS)的表达,无法进行放射性碘治疗,总体预后较差。因此,逆转NIS在DTC中的表达进而提高碘摄取能力成为近年来的研究热点。本文就NIS的调控、抑制NIS表达的分子机制以及放射性碘难治性DTC再分化治疗进行综述。 展开更多
关键词 放射性碘难治性甲状腺癌 钠碘转运蛋白 信号通路 放射性碘治疗
下载PDF
锌铊共掺碘化钠晶体的生长及闪烁性能
18
作者 田东升 张斌 +5 位作者 尹祖荣 力茂林 徐悟生 张镇玺 贾永超 徐朝鹏 《发光学报》 EI CAS CSCD 北大核心 2023年第10期1797-1802,共6页
采用坩埚下降法生长了NaI∶Zn(0,0.05%,0.08%,0.4%),Tl(0.18%)晶体。对晶体样品进行了X射线粉末衍射、电感耦合等离子体发射光谱以及紫外可见近红外透射光谱测试。结果表明,生长的晶体具有单一的物相,Zn和Tl离子掺杂并没有改变NaI的晶... 采用坩埚下降法生长了NaI∶Zn(0,0.05%,0.08%,0.4%),Tl(0.18%)晶体。对晶体样品进行了X射线粉末衍射、电感耦合等离子体发射光谱以及紫外可见近红外透射光谱测试。结果表明,生长的晶体具有单一的物相,Zn和Tl离子掺杂并没有改变NaI的晶体结构;随着Zn掺杂浓度的增加,晶体内的Zn^(2+)离子浓度增加、Tl^(+)离子浓度下降;晶体透过率随Zn掺杂浓度的增加呈现先增大后减小的趋势,Zn掺杂浓度为0.08%时,样品的透过率最高,且所有样品在350~700 nm波段的透过率均高于70%。经过切割、打磨、抛光、封装等工序将NaI∶Zn,Tl晶体封装成辐射探测元件。闪烁性能测试结果表明,在137Cs放射源激发下,Zn掺量为0.05%、0.08%时的NaI∶Zn,Tl晶体的能量分辨率≤6.80%,光输出相对于NaI∶Tl晶体增加6%~10%,这有利于NaI晶体在高能粒子探测领域的进一步应用。 展开更多
关键词 碘化钠晶体 Zn掺杂 坩埚下降法 晶体生长 透过率 能量分辨率 相对光输出
下载PDF
Triphenylphosphine and sodium iodide: a new catalyst combination to rival precious metal complexes in visible light photoredox catalysis 被引量:2
19
作者 Adam Noble Varinder K.Aggarwal 《Science China Chemistry》 SCIE EI CAS CSCD 2019年第9期1083-1084,共2页
Photoredox catalysis has changed the landscape of modern synthetic organic chemistry by prompting a dramatic increase in research activity into reactions that proceed through free radical intermediates.
关键词 TRIPHENYLPHOSPHINE sodium iodide VISIBLE light PHOTOREDOX CATALYSIS
原文传递
治疗用碘[^(131)I]化钠胶囊体外溶出研究
20
作者 于坤茹 韦贤理 +2 位作者 马超 吴洁 李星垣 《同位素》 CAS 2023年第4期435-439,共5页
为建立放射性药品溶出度实时在线检测装置,本研究测量自制治疗用碘[^(131)I]化钠胶囊溶出度,并与被仿制剂进行溶出曲线比对。结果显示,自制胶囊与被仿制剂体外溶出行为一致。经验证,本分析方法专属性良好;活度浓度在1.9~108.4μCi/mL范... 为建立放射性药品溶出度实时在线检测装置,本研究测量自制治疗用碘[^(131)I]化钠胶囊溶出度,并与被仿制剂进行溶出曲线比对。结果显示,自制胶囊与被仿制剂体外溶出行为一致。经验证,本分析方法专属性良好;活度浓度在1.9~108.4μCi/mL范围内线性良好,相关系数>0.999;方法准确可靠,回收率均在90%~110%范围内,RSD<5%;精密度良好。 展开更多
关键词 治疗用碘[^(131)I]化钠胶囊 放射性药品 体外溶出曲线 实时测量
下载PDF
上一页 1 2 16 下一页 到第
使用帮助 返回顶部